Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dimitrios Kalaitzoglou"'
Autor:
Mariam Awan, Aya Elshalakany, Dimitrios Kalaitzoglou, Siddharth Sinha, Nida Kalyal, Mathew Gallagher, Daniel Richardson, Ahmed Abougamil, Melissa Silva, Anna Oviedova, Sabina Patel, Ana Mirallave-Pescador, Cristina Bleil, Bassel Zebian, Richard Gullan, Keyoumars Ashkan, Francesco Vergani, Ranjeev Bhangoo, José Pedro Lavrador
Publikováno v:
Brain and Spine, Vol 3, Iss , Pp 102179- (2023)
Externí odkaz:
https://doaj.org/article/e6eef1ea14804e73abde7205e3bd1836
Autor:
Francesca Vitulli, Dimitrios Kalaitzoglou, Christos Soumpasis, Alba Díaz-Baamonde, José David Siado Mosquera, Richard Gullan, Francesco Vergani, Keyoumars Ashkan, Ranjeev Bhangoo, Ana Mirallave-Pescador, Jose Pedro Lavrador
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 8, p 1278 (2023)
Surgical management of deep-seated brain tumors requires precise functional navigation and minimally invasive surgery. Preoperative mapping using navigated transcranial magnetic stimulation (nTMS), intraoperative neurophysiological monitoring (IONM),
Externí odkaz:
https://doaj.org/article/e2c9cc85b403494ba534535196f3e208
Autor:
Keyoumars Ashkan, Asfand Baig Mirza, Christos Soumpasis, Christoforos Syrris, Dimitrios Kalaitzoglou, Chaitanya Sharma, Zachariah Joseph James, Abbas Khizar Khoja, Razna Ahmed, Amisha Vastani, James Bartram, Kazumi Chia, Omar Al-Salihi, Angela Swampilai, Lucy Brazil, Ross Laxton, Zita Reisz, Istvan Bodi, Andrew King, Richard Gullan, Francesco Vergani, Ranjeev Bhangoo, Safa Al-Sarraj, Jose Pedro Lavrador
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 6, p 999 (2023)
MGMT promoter methylation is related to the increased sensitivity of tumour tissue to chemotherapy with temozolomide (TMZ) and thus to improved patient survival. However, it is unclear how the extent of MGMT promoter methylation affects outcomes. In
Externí odkaz:
https://doaj.org/article/492fecbe75404b078a769c15a705c22a
Autor:
Asfand Baig Mirza, Jose Pedro Lavrador, Axumawi Gebreyohanes, Amisha Vastani, Musa China, Dimitrios Kalaitzoglou, James Bartram, Hazem Eid, Christina Bleil, David Bell, Nicholas Thomas, Irfan Malik, Gordan Grahovac
Publikováno v:
Operative Neurosurgery. 24:391-403
Autor:
Lavrador, Keyoumars Ashkan, Asfand Baig Mirza, Christos Soumpasis, Christoforos Syrris, Dimitrios Kalaitzoglou, Chaitanya Sharma, Zachariah Joseph James, Abbas Khizar Khoja, Razna Ahmed, Amisha Vastani, James Bartram, Kazumi Chia, Omar Al-Salihi, Angela Swampilai, Lucy Brazil, Ross Laxton, Zita Reisz, Istvan Bodi, Andrew King, Richard Gullan, Francesco Vergani, Ranjeev Bhangoo, Safa Al-Sarraj, Jose Pedro
Publikováno v:
Journal of Personalized Medicine; Volume 13; Issue 6; Pages: 999
MGMT promoter methylation is related to the increased sensitivity of tumour tissue to chemotherapy with temozolomide (TMZ) and thus to improved patient survival. However, it is unclear how the extent of MGMT promoter methylation affects outcomes. In
Autor:
Paraschos Archontakis-Barakakis, Wei-Jia Li, Dimitrios Kalaitzoglou, Stefanos Giannopoulos, Leonidas Palaiodimos, Robert T. Faillace, Damianos G Kokkinidis, Yu-Chiang Wang, Lazaros Tzelves, Apostolos Manolopoulos
Publikováno v:
World Journal of Cardiology
Background Most of the randomized clinical trials that led to the wide use of non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) originated from western countries. Aim To systematically review
Autor:
Paraschos Archontakis‐Barakakis, Weijia Li, Dimitrios Kalaitzoglou, Lazaros Tzelves, Apostolos Manolopoulos, Stefanos Giannopoulos, Grigorios Giamouzis, George Giannakoulas, Apostolos Batsidis, Leonidas Palaiodimos, George Ntaios, Gregory Y. H. Lip, Damianos G. Kokkinidis
Publikováno v:
British journal of clinical pharmacologyREFERENCES. 88(11)
Observational studies have investigated the effectiveness and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) used in nonvalvular atrial fibrillation. We performed a systematic review and meta-analysis assessing the risk
Autor:
Asfand Baig Mirza, Axumawi Gebreyohanes, James Knight, James Bartram, Amisha Vastani, Dimitrios Kalaitzoglou, Jose Pedro Lavrador, Ahilan Kailaya-Vasan, Eleni Maratos, David Bell, Nick Thomas, Richard Gullan, Irfan Malik, Gordan Grahovac
Publikováno v:
Acta neurochirurgica. 164(10)
Intramedullary spinal cord tumours (IMSCTs) are comparatively rare neoplasms. We present a single-centre clinical case series of adult patients with surgically managed IMSCTs.We performed a retrospective analysis of electronic patient records in the
Autor:
Grigorios Kalaitzidis, Pavlos Gr. Myserlis, Konstantinos I. Avgerinos, Dimitrios Kalaitzoglou, Vasileios-Arsenios Lioutas, Antonia Malli
Publikováno v:
Journal of Neurology. 265:1497-1510
BACKGROUND AND AIMS: Due to common pathophysiological findings of Alzheimer’s disease (AD) with diabetes mellitus (DM), insulin has been suggested as a possible treatment of AD or mild cognitive impairment (MCI). A safe alternative of IV insulin is
Autor:
Antonia Malli, Michael Miligkos, Dimitrios Kalaitzoglou, Damianos G. Kokkinidis, Grigorios Kalaitzidis, Pavlos Gr. Myserlis, Andreas P. Kalogeropoulos
Publikováno v:
Heart failure reviews. 22(1)
Cognitive impairment and dementia are established complications of heart failure (HF) in adult patients and impair medication adherence and self-care. Atrial fibrillation (AF) is suggested to play an independent role in the cognitive decline in patie